MedPath

Assessment of Bone Mineral Density During Pregnancy

Phase 1
Completed
Conditions
Bone Mineral Density Quantitative Trait Locus 3
Interventions
Radiation: calcaneal quantitative ultrasound assessment
Registration Number
NCT02480023
Lead Sponsor
Ain Shams University
Brief Summary

BMD at peripheral sites typically heel is measured by Ultrasound densitometry at Ain Shams Maternity hospital.

Detailed Description

Consecutive patients with singleton pregnancies between 36 and 39 weeks booked at a general obstetric clinic in a regional hospital will be recruited for the study. The obstetric department is a tertiary referral center in the region and part of a university teaching unit which catered to an annual delivery of around 10,000 women. A group of first trimester pregnant women with nearly the same age is recruited as controls.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
173
Inclusion Criteria
  1. females during 3rd trimister
Exclusion Criteria
  1. Secondary causes of bone loss such as hyperparathyroidism.
  2. Co-morbidities that would interfere with bone metabolism as clinically significant liver or renal disease.
  3. Physical or orthopedic disabilities that would place the subject at risk or limit their ability to perform US.
  4. Taking medication known to affect bone including steroid hormones.

Histories of smoking and use of oral contraceptives (OCs) are not exclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
healthcarecalcaneal quantitative ultrasound assessmentQUS for calcaneus bone of right foot will be done for this group of Pregnant women at the third trimester
Primary Outcome Measures
NameTimeMethod
Bone mineral density loss during pregnancy that is detectable by quantitative ultrasound at the os calcis.6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of medicine, ain shams university

🇪🇬

Cairo, Al Qahirah, Egypt

© Copyright 2025. All Rights Reserved by MedPath